319
Views
36
CrossRef citations to date
0
Altmetric
Reviews

Tumour-immune cell interactions modulated by chemokines

, PhD, , MD, , MS, , MS, , PhD & , MD
Pages 269-290 | Published online: 25 Feb 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Teilo H. Schaller, Kristen A. Batich, Carter M. Suryadevara, Rupen Desai & John H. Sampson. (2017) Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3. Expert Review of Clinical Immunology 13:11, pages 1049-1060.
Read now
Karin Jöhrer, Christian Ploner, Shanmugapriya Thangavadivel, Philipp Wuggenig & Richard Greil. (2015) Adipocyte-derived players in hematologic tumors: useful novel targets?. Expert Opinion on Biological Therapy 15:1, pages 61-77.
Read now

Articles from other publishers (34)

Mojgan Noroozi Karimabad, Gholamhossein Hassanshahi, Nicholas G. Kounis, Virginia Mplani, Pavlos Roditis, Christos Gogos, Maria Lagadinou, Stelios F. Assimakopoulos, Periklis Dousdampanis & Ioanna Koniari. (2022) The Chemokines CXC, CC and C in the Pathogenesis of COVID-19 Disease and as Surrogates of Vaccine-Induced Innate and Adaptive Protective Responses. Vaccines 10:8, pages 1299.
Crossref
Jiangyuan Wang, Cong Peng, Wentao Dai, Xiang Chen, Jing Meng & Taijiao Jiang. (2022) Exploring Tumor Immune Microenvironment and Its Associations With Molecular Characteristics in Melanoma. Frontiers in Oncology 12.
Crossref
Constanza Savid-Frontera, Maria E Viano, Natalia S Baez, Della Reynolds, Mariana Matellon, Howard A Young & Maria C Rodriguez-Galan. (2022) Safety levels of systemic IL-12 induced by cDNA expression as a cancer therapeutic. Immunotherapy 14:2, pages 115-133.
Crossref
Mojgan Noroozi Karimabad, Nicholas G. Kounis, Gholamhossein Hassanshahi, Farzaneh Hassanshahi, Virginia Mplani, Ioanna Koniari, Ming-Yow Hung & Ali Esmaeili Nadimi. (2021) The Involvement of CXC Motif Chemokine Ligand 10 (CXCL10) and Its Related Chemokines in the Pathogenesis of Coronary Artery Disease and in the COVID-19 Vaccination: A Narrative Review. Vaccines 9:11, pages 1224.
Crossref
Prashant Jain, Chethan D. Shanthamurthy, Shani Leviatan Ben-Arye, Robert J. Woods, Raghavendra Kikkeri & Vered Padler-Karavani. (2021) Discovery of rare sulfated N -unsubstituted glucosamine based heparan sulfate analogs selectively activating chemokines . Chemical Science 12:10, pages 3674-3681.
Crossref
Jia‐Wei Shi, Hui‐Li Yang, Deng‐Xuan Fan, Shao‐Liang Yang, Xue‐Min Qiu, Yan Wang, Zhen‐Zhen Lai, Si‐Yao Ha, Lu‐Yu Ruan, Hui‐Hui Shen, Wen‐Jie Zhou & Ming‐Qing Li. (2020) The role of CXC chemokine ligand 16 in physiological and pathological pregnancies. American Journal of Reproductive Immunology 83:4.
Crossref
Lei Nie, Yongkun Wei, Fei Zhang, Yi-Hsin Hsu, Li-Chuan Chan, Weiya Xia, Baozhen Ke, Cihui Zhu, Rong Deng, Jun Tang, Jun Yao, Yu-Yi Chu, Xixi Zhao, Ye Han, Junwei Hou, Longfei Huo, How-Wen Ko, Wan-Chi Lin, Hirohito Yamaguchi, Jung-Mao Hsu, Yi Yang, Dean N. Pan, Jennifer L. Hsu, Celina G. Kleer, Nancy E. Davidson, Gabriel N. Hortobagyi & Mien-Chie Hung. (2019) CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer. Nature Communications 10:1.
Crossref
Gazi YildirimRukset AttarSeda Gulec-YilmazSelvi DumanTurgay Isbir. (2017) Association of CCR2 ( + 190 G/A) Gene Variants and Ovarian Cancer Severity . Genetic Testing and Molecular Biomarkers 21:8, pages 512-515.
Crossref
Vahid Tavakolian Ferdousie, Maryam Mohammadi, Gholamhossein Hassanshahi, Hossein Khorramdelazad, Soudeh Khanamani Falahati-pour, Mohsen Mirzaei, Mohammad Allah Tavakoli, Zahra Kamiab, Zahra Ahmadi, Reza Vazirinejad, Effat Shahrabadi, Ioanna Koniari, Nicholas G Kounis & Ali Esmaeili Nadimi. (2017) Serum CXCL10 and CXCL12 chemokine levels are associated with the severity of coronary artery disease and coronary artery occlusion. International Journal of Cardiology 233, pages 23-28.
Crossref
Won Jong Jin, Bongjun Kim, Darong Kim, Hea-Young Park Choo, Hong-Hee Kim, Hyunil Ha & Zang Hee Lee. (2017) NF-κB signaling regulates cell-autonomous regulation of CXCL10 in breast cancer 4T1 cells. Experimental & Molecular Medicine 49:2, pages e295-e295.
Crossref
Jamileh A. Nabizadeh, Helga D. Manthey, Frederik J. Steyn, Weiyu Chen, Alexander Widiapradja, Fazrena N. Md Akhir, Glen M. Boyle, Stephen M. Taylor, Trent M. Woodruff & Barbara E. Rolfe. (2016) The Complement C3a Receptor Contributes to Melanoma Tumorigenesis by Inhibiting Neutrophil and CD4+ T Cell Responses. The Journal of Immunology 196:11, pages 4783-4792.
Crossref
Di-Yi Wang, Li-Ping Zou, Xiao-Jia Liu, Hong-Guang Zhu & Rong Zhu. (2015) Chemokine Expression Profiles of Human Hepatoma Cell Lines Mediated by Hepatitis B Virus X Protein. Pathology & Oncology Research 22:2, pages 393-399.
Crossref
Yuan-Ya Liao, Hsiao-Chi Tsai, Pei-Yu Chou, Shih-Wei Wang, Hsien-Te Chen, Yu-Min Lin, I-Ping Chiang, Tzu-Ming Chang, Shao-Keh Hsu, Ming-Chih Chou, Chih-Hsin Tang & Yi-Chin Fong. (2015) CCL3 promotes angiogenesis by dysregulation of miR-374b/ VEGF-A axis in human osteosarcoma cells. Oncotarget 7:4, pages 4310-4325.
Crossref
Chanyu Yue, Shudan Shen, Jiehui Deng, Saul J. Priceman, Wenzhao Li, Austin Huang & Hua Yu. (2015) STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis. Cancer Immunology Research 3:8, pages 864-870.
Crossref
Yongqian Chen, Ye Tian, Zhengguo Ji, Zhi Liu & Donghao Shang. (2015) CC-chemokine receptor 7 is overexpressed and correlates with growth and metastasis in prostate cancer. Tumor Biology 36:7, pages 5537-5541.
Crossref
Degui Geng, Sabina Kaczanowska, Alexander Tsai, Kenisha Younger, Augusto Ochoa, Aaron P. Rapoport, Sue Ostrand-Rosenberg & Eduardo Davila. (2015) TLR5 Ligand–Secreting T Cells Reshape the Tumor Microenvironment and Enhance Antitumor Activity. Cancer Research 75:10, pages 1959-1971.
Crossref
Fayçal Djenidi, Julien Adam, Aïcha Goubar, Aurélie Durgeau, Guillaume Meurice, Vincent de Montpréville, Pierre Validire, Benjamin Besse & Fathia Mami-Chouaib. (2015) CD8+CD103+ Tumor–Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients. The Journal of Immunology 194:7, pages 3475-3486.
Crossref
Cheng Peng, Keliang Zhou, Sensheng An & Jie Yang. (2014) The effect of CCL19/CCR7 on the proliferation and migration of cell in prostate cancer. Tumor Biology 36:1, pages 329-335.
Crossref
Laetitia Fend, Tanja Gatard-Scheikl, Jacqueline Kintz, Murielle Gantzer, Emmanuelle Schaedler, Karola Rittner, Sandrine Cochin, Sylvie Fournel & Xavier Préville. (2014) Intravenous Injection of MVA Virus Targets CD8+ Lymphocytes to Tumors to Control Tumor Growth upon Combinatorial Treatment with a TLR9 Agonist. Cancer Immunology Research 2:12, pages 1163-1174.
Crossref
Ke-qin Luo, Yi-ni Shi & Ji-cai Peng. (2014) The effect of chemokine CC motif ligand 19 on the proliferation and migration of hepatocellular carcinoma. Tumor Biology 35:12, pages 12575-12581.
Crossref
Katarzyna Franciszkiewicz, Marie Boutet, Ludiane Gauthier, Isabelle Vergnon, Kelly Peeters, Olivier Duc, Benjamin Besse, Geneviève de Saint Basile, Salem Chouaib & Fathia Mami-Chouaib. (2014) Synaptic Release of CCL5 Storage Vesicles Triggers CXCR4 Surface Expression Promoting CTL Migration in Response to CXCL12. The Journal of Immunology 193:10, pages 4952-4961.
Crossref
Mei-Rong Du, Song-Cun Wang & Da-Jin Li. (2014) The integrative roles of chemokines at the maternal–fetal interface in early pregnancy. Cellular & Molecular Immunology 11:5, pages 438-448.
Crossref
Jun Zeng, Xudan Yang, Lin Cheng, Rui Liu, Yunlong Lei, Dandan Dong, Fanghua Li, Quek Choon Lau, Longfei Deng, Edouard C Nice, Ke Xie & Canhua Huang. (2013) Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resection. Journal of Translational Medicine 11:1.
Crossref
Weilin Wang, Pengfei Huang, Lufei Zhang, Jianfeng Wei, Qingsong Xie, Qiang Sun, Xiaohu Zhou, Haiyang Xie, Lin Zhou & Shusen Zheng. (2013) Antitumor efficacy of C-X-C motif chemokine ligand 14 in hepatocellular carcinoma in vitro and in vivo . Cancer Science 104:11, pages 1523-1531.
Crossref
Rajesh Kumar Sharma, Zinal Chheda, Venkatakrishna Rao Jala & Bodduluri Haribabu. (2013) Expression of Leukotriene B4 Receptor-1 on CD8+ T Cells Is Required for Their Migration into Tumors To Elicit Effective Antitumor Immunity. The Journal of Immunology 191:6, pages 3462-3470.
Crossref
E Goguet-Surmenian, P Richard-Fiardo, E Guillemot, M Benchetrit, A Gomez-Brouchet, P Buzzo, B Karimdjee-Soilihi, P Alemanno, J-F Michiels, A Schmid-Alliana & H Schmid-Antomarchi. (2013) CXCR7-mediated progression of osteosarcoma in the lungs. British Journal of Cancer 109:6, pages 1579-1585.
Crossref
Katarzyna Franciszkiewicz, Alexandre Boissonnas, Marie Boutet, Christophe Combadière & Fathia Mami-Chouaib. (2012) Role of Chemokines and Chemokine Receptors in Shaping the Effector Phase of the Antitumor Immune Response. Cancer Research 72:24, pages 6325-6332.
Crossref
Stephen M. Ansell, Matthew J. Maurer, Steven C. Ziesmer, Susan L. Slager, Thomas M. Habermann, Brian K. Link, Thomas E. Witzig, William R. Macon, Ahmet Dogan, James R. Cerhan & Anne J. Novak. (2012) Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients. American Journal of Hematology 87:9, pages 865-869.
Crossref
Daniel P. Steinfort, Alpha Tsui, James Grieve, Margaret L. Hibbs, Gary P. Anderson & Louis B. Irving. (2012) Sarcoidal reactions in regional lymph nodes of patients with early stage non–small cell lung cancer predict improved disease-free survival: a pilot case-control study. Human Pathology 43:3, pages 333-338.
Crossref
Xing Gu, Hao Wang, Aihua Wang, Tonghai Dou, Peng Qi, Qiang Ji, Hui Li & Chunfang Gao. (2011) An intronic polymorphism rs2237062 in the CXCL14 gene influences HBV-related HCC progression in Chinese population. Molecular Biology Reports 39:2, pages 797-803.
Crossref
Peter Göttle, David Kremer, Sebastian Jander, Veysel Ödemis, Jürgen Engele, Hans‐Peter Hartung & Patrick Küry. (2010) Activation of CXCR7 receptor promotes oligodendroglial cell maturation. Annals of Neurology 68:6, pages 915-924.
Crossref
Xiaoyu Xiang, Anton Poliakov, Cunren Liu, Yuelong Liu, Zhong‐bin Deng, Jianhua Wang, Ziqiang Cheng, Spandan V. Shah, Gui‐Jun Wang, Liming Zhang, William E. Grizzle, Jim Mobley & Huang‐Ge Zhang. (2009) Induction of myeloid‐derived suppressor cells by tumor exosomes. International Journal of Cancer 124:11, pages 2621-2633.
Crossref
Martin AugstenChristina HägglöfEleonor OlssonClaudia StolzPanagiotis TsagozisTetyana LevchenkoMitchell J. Frederick, Åke BorgPatrick Micke, Lars EgevadArne Östman. (2009) CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth. Proceedings of the National Academy of Sciences 106:9, pages 3414-3419.
Crossref
Carmela Rita Balistreri, Giuseppe Carruba, Maurizio Calabrò, Ildegarda Campisi, Daniele Di Carlo, Domenico Lio, Giuseppina Colonna-Romano, Giuseppina Candore & Calogero Caruso. (2009) CCR5 Proinflammatory Allele in Prostate Cancer Risk. Annals of the New York Academy of Sciences 1155:1, pages 289-292.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.